Julie Fu

2.6k total citations
7 papers, 35 citations indexed

About

Julie Fu is a scholar working on Molecular Biology, Epidemiology and Hematology. According to data from OpenAlex, Julie Fu has authored 7 papers receiving a total of 35 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Hematology. Recurrent topics in Julie Fu's work include Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Julie Fu is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Julie Fu collaborates with scholars based in United States. Julie Fu's co-authors include Haili Cui, John L. Berk, David C. Seldin, Raymond L. Comenzo, Vaishali Sanchorawala, Fangui Sun, Carl O’Hara, Lisa X. Lee, Muhammad Wasif Saif and Nadeem Bilani and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Amyloid.

In The Last Decade

Julie Fu

7 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Fu United States	4	21	14	11	6	6	7	35
J Buenestado Spain	3	8 0.4×	11 0.8×	11 1.0×	3 0.5×	7 1.2×	6	59
J.-P. Arnault France	4	18 0.9×	11 0.8×	30 2.7×	4 0.7×	3 0.5×	11	65
Samuel Ardois France	4	16 0.8×	3 0.2×	4 0.4×	6 1.0×	2 0.3×	6	29
Marija K. Simic Australia	5	23 1.1×	9 0.6×	23 2.1×		2 0.3×	6	63
Jazmean K. Williams United States	3	14 0.7×	10 0.7×	9 0.8×	2 0.3×	2 0.3×	3	42
Caren Gentile United States	6	9 0.4×	9 0.6×	5 0.5×	7 1.2×	3 0.5×	7	48
F. Duchêne France	3	22 1.0×	7 0.5×	8 0.7×	3 0.5×		5	45
И. М. Марусенко Russia	5	5 0.2×	9 0.6×	4 0.4×	5 0.8×	6 1.0×	18	58
Rincy Kurian United Kingdom	3	26 1.2×	14 1.0×	8 0.7×		5 0.8×	3	58
Ana Gorosquieta Spain	4	27 1.3×	8 0.6×	8 0.7×	12 2.0×	8 1.3×	9	58

Countries citing papers authored by Julie Fu

Since Specialization

Citations

This map shows the geographic impact of Julie Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Fu more than expected).

Fields of papers citing papers by Julie Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Fu. The network helps show where Julie Fu may publish in the future.

Co-authorship network of co-authors of Julie Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Fu. A scholar is included among the top collaborators of Julie Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Fu. Julie Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Gulati, Shuchi, Surbhi Shah, Amit Kulkarni, et al.. (2021). Thrombotic complications with SARS-CoV-2 infection in patients with cancer on high-risk therapies: Data from the COVID-19 and Cancer Consortium (CCC19).. Journal of Clinical Oncology. 39(15_suppl). e18788–e18788. 2 indexed citations

2.

Chaulagain, Chakra P., et al.. (2020). How We Manage Systemic Immunoglobulin Heavy Chain Amyloidosis (AH Amyloidosis) and Immunoglobulin Heavy-and-Light-Chain Amyloidosis (AH/AL Amyloidosis). Clinical Lymphoma Myeloma & Leukemia. 20(11). e826–e831. 5 indexed citations

3.

Fu, Julie, et al.. (2019). A case report – renal heavy chain amyloidosis and T-cell large granular lymphocytic leukaemia. Amyloid. 26(sup1). 130–131. 1 indexed citations

4.

Fu, Julie, et al.. (2019). A Case of T-Cell Large Granular Lymphocytic Leukemia and Renal Immunoglobulin Heavy Chain Amyloidosis. American Journal of Case Reports. 20. 43–47. 4 indexed citations

5.

Saif, Muhammad Wasif, et al.. (2018). Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors. SHILAP Revista de lepidopterología. 4(1). 64–71. 4 indexed citations

6.

Fu, Julie, Jenica Upshaw, Joshua T. Cohen, et al.. (2017). Assessing the risk of cardiac toxicity after contemporary treatment for Hodgkin lymphoma: a systematic review. Leukemia & lymphoma. 59(8). 1976–1980. 3 indexed citations

7.

Fu, Julie, David C. Seldin, John L. Berk, et al.. (2014). Lymphadenopathy as a manifestation of amyloidosis: a case series. Amyloid. 21(4). 256–260. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact